Absci to Report Third Quarter Financial Results on November 9, 2021
Absci Corporation (Nasdaq: ABSI) announced it will release its Q3 2021 financial results on November 9, 2021. The company will host a webcast conference call at 5:30 AM PT / 8:30 AM ET to discuss the results. Absci focuses on drug discovery through deep learning AI and synthetic biology to enhance protein therapeutics. Their Integrated Drug Creation™ Platform allows identification of new drug targets and optimal biotherapeutic candidates efficiently. The webcast will be available on their website and archived for later access.
- Announcement of Q3 2021 financial report date, indicating ongoing business activity.
- Webcast conference call scheduled for direct communication with investors.
- Focus on innovative drug discovery using deep learning AI and synthetic biology.
- None.
VANCOUVER, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will report financial results for the third quarter 2021 on Tuesday, November 9, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.absci.com. The webcast will be archived and available for replay after the event.
About Absci
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™.
Availability of Other Information about Absci
Investors and others should note that we routinely communicate with investors and the public using our website (www.absci.com) and our investor relations website (investors.absci.com), including without limitation, through the posting of investor presentations, SEC filings, press releases, public conference calls and webcasts on these websites. The information that we post on these websites could be deemed to be material information. As a result, investors, the media, and others interested in Absci are encouraged to review this information on a regular basis. The contents of our website, or any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
Investor Contact
investors@absci.com
Media Contact
press@absci.com
FAQ
When will Absci report its Q3 2021 financial results?
What time is the Absci Q3 2021 earnings conference call?
Where can I listen to the Absci Q3 2021 earnings call?
What is Absci Corporation's focus in drug discovery?
